3. Medical Emergencies: Pulmonary Flashcards

1
Q

◦ Extrathoracic components are the ____, trachea.
◦ Intrathoracic components are the ____, primarily. Then the trachea, bronchi, bronchioles, and alveoli which are involved in gas exchange.

A

mouth

lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Airway Physiology

● Airways become ____ as you move toward the periphery but the total cross-sectional area ____

A

smaller

increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Airway Physiology

Primary thing here is: the trachea has ____. They’ll maintain support of the area. Because they’re ____-shaped, it allows for some distensibility of that airway as well. The ____ portion is NOT cartilage, so it can change in terms of diameter. But the cartilage helps support the airway and keeps them open.

As we go further down into the bronchi, there will be ____ bronchi that go to the lobes of the right lung, and only ____ bronchi that go to the lobes of the left lung.

A

cartilaginous rings
C
posterior

3
2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Airway Physiology

We’ll see the ____ here at the end. Finally, the alveolar sacs and alveoli. These are normal-looking alveoli. You can see the tremendous amount of cross-sectional area, and that is where CO2 and O2 are going to be exchanged.

A

terminal bronchioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Airway Physiology

● Airways are held open by ____ support and by ____ differences

A

structural

pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Physiology of Breathing
● Central and peripheral respiratory and the sensory receptors
● The central chemoreceptors respond to ____ and the
peripheral chemoreceptors respond to ____
● The normal respiratory rate (RR) is ____ breaths per minute

A

carbon dioxide (CO2)
oxygen (O2)
14-16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Exhalation and Inspiration

Here’s a chest xray of someone that’s taking a breath in (right). You can see the tremendous increase in lung volume. The diaphragm contracts.

And then somebody that’s exhaling (left). Diaphragm is ____, so there is less lung volume.

We also see these little vascular markings. These white markings are ____. There’s not as much air in the lungs, so you can see those prominent markings. In patients with ____, those will be very prominent. That’s one of the reads we’ll see on a chest x-ray, prominent vascular markings suggestive of CHF. You’ll also see an enlargement of the ____ (its silouhette will be larger).

On the right lung, you can’t see those vascular markings quite as much as you could during ____.

A
up
vascular markings
CHF
heart
exhalation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pulmonary Symptoms
● ____
● ____
● ____

A

dyspnea
wheezing
cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dyspnea
● The sensation of difficulty with ____
● ____ or chronic
● Can be triggered by any stimulus that increases the need for ____

A

breathing
acute
oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Differential Diagnosis of Dyspnea

● Chronic obstructive
pulmonary disease 
● Asthma 
● \_\_\_\_
obstruction 
● \_\_\_\_ 
● \_\_\_\_ 
● \_\_\_\_ 
● \_\_\_\_
● Congestive heart
failure 
● \_\_\_\_ infarction 
● \_\_\_\_
disorders 
● \_\_\_\_
A
upper airway
aspiration
pulmonary embolism
pneumothorax
laryngospasm

myocardial
neuromuscular
anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pulmonary Diseases
● COPD
- ____
- ____

● Asthma

A

bronchitis

emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COPD
● Affects 14 million people
● ____ leading cause of death

A

fifth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

“Causes of pure emphysema or pure chronic bronchitis are uncommon; patients usually have elements of both diseases. The disease that ____ receives the diagnostic label.”

A

predominates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
● Chronic bronchitis 
“Blue bloaters” 
Frequency \_\_\_\_ 
Chronic productive \_\_\_\_ Copious, \_\_\_\_ sputum
\_\_\_\_ dyspnea 
Frequent \_\_\_\_ infections
● Emphysema 
“Pink puffers” 
\_\_\_\_ chested 
\_\_\_\_ not prominent
\_\_\_\_ sputum
\_\_\_\_ dyspnea
Few \_\_\_\_ infections
A
overweight
cough
mucopurulent
mild
respiratory
barrel
cough
scant
severe
respiratory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chronic Bronchitis
“Excessive tracheobronchial mucous production sufficient to cause cough with expectoration for at least ____ months of the year for ____ consecutive years”

A

3

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chronic Bronchitis

This is what it looks like pathologically
You’ll see ____ cells in the lining of the airway that produce mucus
Also bronchial glands: only found in the ____ glands
You’ll see thick sputum in the middle of the airway and these big mucus ____ (you have to clear the plugs in order to breathe)

A

goblet
larger
plugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Emphysema

“Distension of the air space ____ to the terminal bronchioles with destruction of ____”

A

distal

alveolar septa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Emphysema and chronic bronchitis are clinically managed in an ____ fashion.

Both patients with emphysema and chronic bronchitis will be managed exactly the same way clinically.

Patients with COPD will get more ____, but patients with emphysema are also treated with antibiotics (not as frequently tho). They will be on some kind of either B-2 agonist or parasympathetic blocker.
In essence, there’s a blur between the 2 categories and patients have features of both. Ultimately, they’re not managed identically, but pretty close!

A

identical

antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Pulmonary Function Tests
● \_\_\_\_
● \_\_\_\_
Measurement
● \_\_\_\_ Blood Gases

Arterial blood gases: done in a hospital-type setting when we want to know these numbers. These patients might be in an ICU for an extended period of time. We won’t get these values as quickly as we will ____ and ____ measurement.

A

spirometry
peak flow
arterial

spirometry
peak flow

20
Q

Lung Volumes
● Tidal Volume (TV)– the amount of air that moves into the lungs with each ____ or the amount of air that moves out of the lungs with each ____

● Vital Capacity (VC) – ____ volume a person can ____ after full inspiration

● FEV 1 (forced expiratory volume in one second)
The amount of air one can ____ in one second after full ____.
FEV1 is a ____ of vital capacity

normally > 75% of V.C. – ____ with COPD

A

inspiration
expiration

maximum
exhale

expire
inspiration
percentage
decreases

21
Q

Lung Volumes

VC, after full breath of air, how much air can they get out of the lung?

The only thing remaining will be the ____.

FEV1 is going to be a portion of this ____. It’s gonna vary depending on the ____.

A

residual volume
vital capacity
individual

22
Q
Spirometry
● Provides the most \_\_\_\_
assessment of degree of
impairment 
● Measures \_\_\_\_ and
\_\_\_\_ flow rates as well as
\_\_\_\_ 
● Values are compared to
predicted values based on \_\_\_\_, height, and \_\_\_\_
A
accurate
inspiratory
expiratory
vital capacity
age
gender
23
Q

Spirometry in COPD

FEV1 < ____ liters
FEV1/FVC < ____%

In spirometry, we’ll see FEV1 (the amount of air expired after taking a full breath in after one second) is going to be less than 2L in patients with COPD. It’ll be greater than 2L in patients that don’t have any lung problems.

FEV1 as a ratio over the Forced Vital Capacity is going to be less than 75% in patients with COPD. In patients that don’t have COPD, this number should be greater than 75%.

A

2

75

24
Q

Severity of COPD Correlated with Spirometric Measurement

Normal
% or FEV1/FVC: ____

Mild
% or FEV1/FVC: ____

Moderate
% or FEV1/FVC: ____

Severe
% or FEV1/FVC: ____

A

80-100
75-79
50-74
35-49

25
Q

Peak Flow Meter
● Simple to use
● Patients can track their disease and identify
exacerbations
● Values greater than ____ L/min are normal

● Patient’s ____ best values are important
◆ Less than ____% of personal best value
◆ Peak flow measurement of less than ____ L/min is
high risk

A

300

personal
50
100

26
Q

Arterial Blood Gases

● PaO2
____ mmHg in healthy youngsters and decreases
to ____ mmHg in the elderly

● PaCO2
____ mmHg; ____ with respiratory depression or COPD

● pH –
7.4; becomes ____ acid with ____ carbon
dioxide retention

A

100
80

40
increases

more
increased

27
Q

Summary COPD

● Spirometry:
FEV 1 < ____ liters
FEV1/FVC < ____%

● Arterial blood gases:
PaO2 of ____mmHg

A
two
75
70
80-100
45
28
Q

Dental Management of the Patient with COPD
● ____ chair position
● Local anesthetic as usual, but avoid ____
mandibular or palatal blocks
● Avoid use of ____ in severe disease
● ____-flow supplemental oxygen may be helpful
● Avoid ____ inhalation sedation
● Low-dose oral ____ is acceptable
● Avoid use of ____, narcotics, antihistamines,
and anticholinergics
● If patient is taking steroids, may need ____
● Outpatient ____ contraindicated

A
upright
bilateral
rubber dam
low
nitrous oxide-oxygen
benzodiazepines
barbiturates
supplementation
general anesthesia
29
Q
COPD – Treatment
● Elimination of \_\_\_\_ and
environmental pollutants 
● Aggressive treatment of \_\_\_\_ infections 
● \_\_\_\_-flow oxygen 
● \_\_\_\_
A

smoking
pulmonary
low
medications

30
Q

Medications: Important concepts

● Sympathetic innervation causes ____ and parasympathetic
innervation causes ____
● Most therapies focus on augmenting the
____ pathways rather than blocking parasympathetic pathways
● Receptor specific drugs cause less ____
● Aerosol therapy via a ____-dose inhaler
(MDI) – a small valve allows a specific dose to be
released

A
bronchodilation
bronchoconstriction
sympathetic
side effects
metered
31
Q
Medications
● Bronchodilators
- \_\_\_\_ (i.e.
theophylline)
- \_\_\_\_ stimulants (i.e.
albuterol)
- \_\_\_\_ (i.e.
ipratropium) 

● ____ (2nd line)

A

methylxanthines
beta-adrenergic
anticholinergics
corticosteroids

32
Q

Asthma

“syndrome consisting of ____, cough, and wheezing caused by ____ resulting from a ____ of the tracheobronchial tree”

A

dyspnea
bronchospasm
hyperirritability

33
Q
Asthma vs. COPD 
● Asthma is a \_\_\_\_ obstructive
disease. 
● Respiratory function is fairly
\_\_\_\_ between asthma attacks.
A

reversible

normal

34
Q
Pathophysiology of Asthma 
● Airway \_\_\_\_ 
● Airway \_\_\_\_ 
● During an acute attack
\_\_\_\_, mucosal edema, and mucous \_\_\_\_ lead to narrowing and closure of small peripheral airways
A

reactivity
inflammation
bronchospasm
plugging

35
Q

Asthma

• So similar to what we saw with patients with chronic bronchitis, this is just more of an ____ situation where you’ll have:
◦ mucus in the airway
◦ edema of the lining of the airway
◦ spasm of the bronchus
• So a very narrow airway for air to get through down into the alveoli for exchange of gases

A

acute

36
Q

Incidence of Asthma
● ____ % of children
● ____% of adults

A

10

5

37
Q

Common classifications of Asthma

Extrinsic Asthma 
● \_\_\_\_ onset, commonly
\_\_\_\_ with age 
● \_\_\_\_
manifestations 
● \_\_\_\_ response to
medication 
● \_\_\_\_, extended
symptom-free periods
common
Intrinsic Asthma 
● \_\_\_\_ onset 
● No \_\_\_\_ allergen-
antigen reaction 
● \_\_\_\_ pharmacological
efficacy 
● \_\_\_\_
A
early
decreased
immunological
excellent
seasonal

adult
discernible
reduced
perennial

38
Q
Intrinsic Asthma
● No \_\_\_\_
● Non-responsive to \_\_\_\_
● Normal \_\_\_\_ levels 
● \_\_\_\_-aged adults 
● Initiated by \_\_\_\_, stress, \_\_\_\_
A
family history
skin testing
IgE
middle
exercise
URI's
39
Q

Extrinsic Asthma
● ____ and young adults
● ____ history
● ____ skin test to allergens ● ____ IgE levels

A

children
family
positive
elevated

40
Q

Asthma: Signs and Symptoms

● Paroxysms of dyspnea 
● Productive \_\_\_\_ 
● \_\_\_\_ 
● \_\_\_\_ 
● \_\_\_\_
● Mental \_\_\_\_ 
● Fatigue 
● Anxiety 
● Normal to \_\_\_\_ BP 
● \_\_\_\_
A

cough
wheezing
tachypnea
cyanosis

confusion
increased
tachycardia

41
Q

Treatment of Asthma Attack

1. Eliminate \_\_\_\_ factor/position
patient 
2. \_\_\_\_ 
3. \_\_\_\_ 
4. \_\_\_\_ 
5. \_\_\_\_ 
6. \_\_\_\_ and ventilation
A
precipitating
O2
inhalers
epinephrine
corticosteroids
intubation
42
Q

Therapeutic Agents Commonly Used by Asthmatics
Bronchodialators

____ - albuterol

  • ____ symptomatic treatment
  • salmeterol
  • ____; not appropriate for relief of symptoms

Theophylline
- often used ____ for ____ asthma

A

B2 agonists
first line
long-acting

prophylactically
nocturnal

43
Q

Mast Cell Stabilizer
____ (Intal)

Corticosteroids
\_\_\_\_ 
Beclomethasone dipropionate (Beclovent, Vanceril) 
\_\_\_\_ (Aerobid) 
Triamcinolone acetonide (Azmacort) 
\_\_\_\_ (Decadron Phosphate Respinhaler)

Anticholinergic
____ (Atrovent)

A

cromolyn sodium

prednisone
flunisolide
dexamethasone sodium phosphate

ipratropium bromide

44
Q

Important Points in the History of the Asthmatic Patient
● ____ of hospitalization for asthma
● ____ of intubation during an asthmatic
exacerbation
● ____ and severity of asthmatic exacerbations
● Precipitating factors
● Use of a single versus multiple classes of
____ medications
● ____ and frequency of steroids use (systemic
versus inhaled)
● Previous ____ or pulmonary function
values
● Other associated cardiac or pulmonary diseases

A

history
history
frequency
bronchodilator

45
Q

Dental Management of the Patient with Asthma
● 1. Identification and assessment by ____
a. Type of asthma (allergic vs idiosyncratic)
b. Precipitating factors
c. Age at onset
d. Frequency and severity of attacks
e. How usually managed
f. Medications being taken
g. Necessity of emergency care
● 2. Avoidance of known ____ factors
● 3. Medical ____ for severe, active asthmatic
● 4. Have patient bring ____ to every appointment
and keep it available

A

history
precipitating
consultation
inhaler

46
Q

Dental Management of the Patient with Asthma

● 5. Drug considerations
a. Avoid ____-containing medications (use
____
b. Avoid ____ drugs
NSAIDs)
c. Avoid ____ and narcotics
● 6. Patients taking chronic corticosteroid medication may require ____
● 7. Provision of ____-free environment through
establishment of rapport and openness
● 8. If sedation is required, may be preferable to use
____ inhalation sedation and/or ____ sedation

A
aspirin
acetaminophen
NSAIDs
barbiturates
supplementation
strss
nitrous oxide-oxygen
oral